Can Acute Coronary Syndrome (ACS) occur secondary to plaque disruption?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Coronary Syndrome and Plaque Disruption

Yes, Acute Coronary Syndrome (ACS) primarily occurs secondary to plaque disruption in the coronary arteries. According to multiple authoritative guidelines, plaque disruption is the fundamental pathophysiological mechanism that triggers the cascade of events leading to ACS 1, 2.

Pathophysiology of ACS Secondary to Plaque Disruption

The development of ACS follows a clear pathophysiological sequence:

  1. Plaque Formation and Progression:

    • Initial accumulation of extracellular lipid in the arterial intima
    • Evolution to fibro-fatty stage
    • Progressive weakening of the fibrous cap 1
  2. Plaque Disruption:

    • Occurs through two primary mechanisms:
      • Plaque rupture: More common in men, involves secretion of proteolytic enzymes by macrophages that weaken the fibrous cap 2
      • Plaque erosion: More common in women, characterized by surface erosion without deep rupture 2
  3. Thrombosis Formation:

    • Disruption exposes thrombogenic material to circulating blood
    • Leads to platelet aggregation and thrombus formation
    • The degree of thrombosis determines the clinical presentation 1

Clinical Spectrum Following Plaque Disruption

The clinical manifestation depends on the extent of coronary occlusion following plaque disruption:

  • Unstable Angina (UA):

    • Caused by nonocclusive thrombus on disrupted plaque
    • Transient myocardial ischemia with diminished flow
    • No significant myonecrosis (negative cardiac biomarkers) 2
    • More likely to involve platelet-rich (whitish) thrombus 3
    • More frequently associated with downstream plaque disruption sites 4
  • NSTEMI:

    • Partially occluded coronary artery
    • Subendocardial ischemia
    • Elevated biomarkers of myonecrosis
    • Usually results in non-Q-wave MI 2
  • STEMI:

    • Completely occluded coronary vessel
    • Transmural myocardial ischemia and infarction
    • Elevated biomarkers of myonecrosis
    • Usually results in Q-wave MI 2
    • More likely to involve fibrin-rich (red) thrombus 3
    • More frequently associated with upstream plaque disruption sites 4

Other Mechanisms of ACS

While plaque disruption is the predominant mechanism, other causes of ACS include:

  1. Dynamic obstruction: Coronary spasm or vasoconstriction of epicardial and/or microvascular vessels 1
  2. Progressive mechanical obstruction: Severe narrowing without spasm or thrombus 1
  3. Coronary arterial inflammation 1
  4. Coronary artery dissection: Particularly in peripartal women 1
  5. Secondary UA: Precipitated by conditions extrinsic to the coronary arterial bed that increase myocardial oxygen demand or reduce supply 1

Clinical Implications

Understanding that ACS occurs secondary to plaque disruption has important clinical implications:

  • Therapeutic targets: Antiplatelet and anticoagulant therapies target the thrombotic process, while lipid-lowering therapies aim to stabilize vulnerable plaques 2
  • Risk stratification: Patients with evidence of plaque disruption are at higher risk for recurrent events
  • Prevention strategies: Focus on plaque stabilization through risk factor modification 5

Important Caveats

  • The clinical presentation of ACS depends not only on the degree of plaque disruption but also on the balance between coronary blood supply and myocardial oxygen demand 3
  • The location of plaque disruption (upstream vs. downstream) may influence whether a patient presents with UA or AMI 4
  • Individual patient factors (collateral circulation, pre-existing coronary disease) can modify the clinical presentation following plaque disruption

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Coronary Syndromes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Significance of plaque disruption sites in acute coronary syndrome.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2006

Research

[Risk factors and prevention of acute coronary syndrome].

Nihon rinsho. Japanese journal of clinical medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.